Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda Huff, Neeha Zaidi, Maureen Berg et al.|Nature Communications|2026Cited by 15
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohortsSaurav D. Haldar, Neeha Zaidi, Amanda L. Huff et al.|Cancer Discovery|2026Cited by 1
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L. Huff, Neeha Zaidi, S. Daniel Haldar et al.|Nature Communications|2026Cited by 0